<SEC-DOCUMENT>0001213900-26-067711-index.html : 20260611
<SEC-HEADER>0001213900-26-067711.hdr.sgml : 20260611
<ACCEPTANCE-DATETIME>20260611124358
ACCESSION NUMBER:		0001213900-26-067711
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		51
CONFORMED PERIOD OF REPORT:	20260611
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260611
DATE AS OF CHANGE:		20260611

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADIAL PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001513525
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				800667150
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38323
		FILM NUMBER:		261082315

	BUSINESS ADDRESS:	
		STREET 1:		1180 SEMINOLE TRAIL
		STREET 2:		SUITE 495
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22901
		BUSINESS PHONE:		434-422-9800

	MAIL ADDRESS:	
		STREET 1:		1180 SEMINOLE TRAIL
		STREET 2:		SUITE 495
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22901

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADial Pharmaceuticals, L.L.C.
		DATE OF NAME CHANGE:	20170515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adial Pharmaceuticals, L.L.C.
		DATE OF NAME CHANGE:	20110218
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0294448-8k_adial.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea0294448-8k_adial.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-2.1 <SEQUENCE>2 <FILENAME>ea029444801ex2-1.htm <DESCRIPTION>AGREEMENT AND PLAN OF MERGER, DATED JUNE 11, BY AND AMONG ADIAL PHARMACEUTICALS, INC., ADIAL FIRST MERGER SUB, INC., ADIAL SECOND MERGER SUB, LLC AND AZORA THERAPEUTICS, INC <TEXT> Document 2 - file: ea029444801ex2-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-3.1 <SEQUENCE>3 <FILENAME>ea029444801ex3-1.htm <DESCRIPTION>CERTIFICATE OF DESIGNATION OF SERIES A NON-VOTING CONVERTIBLE PREFERRED STOCK, DATED JUNE 11, 2026 <TEXT> Document 3 - file: ea029444801ex3-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>4 <FILENAME>ea029444801ex4-1.htm <DESCRIPTION>FORM OF PRE-FUNDED WARRANT (FINANCING) <TEXT> Document 4 - file: ea029444801ex4-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.2 <SEQUENCE>5 <FILENAME>ea029444801ex4-2.htm <DESCRIPTION>FORM OF WARRANT (FINANCING) <TEXT> Document 5 - file: ea029444801ex4-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.3 <SEQUENCE>6 <FILENAME>ea029444801ex4-3.htm <DESCRIPTION>FORM OF PRE-FUNDED WARRANT (NOTE EXCHANGE) <TEXT> Document 6 - file: ea029444801ex4-3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.4 <SEQUENCE>7 <FILENAME>ea029444801ex4-4.htm <DESCRIPTION>FORM OF WARRANT (NOTE EXCHANGE) <TEXT> Document 7 - file: ea029444801ex4-4.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>8 <FILENAME>ea029444801ex10-1.htm <DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF JUNE 11, 2026, BY AND AMONG ADIAL PHARMACEUTICALS, INC. AND EACH INVESTOR LISTED ON EXHIBIT A THERETO <TEXT> Document 8 - file: ea029444801ex10-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>9 <FILENAME>ea029444801ex10-2.htm <DESCRIPTION>FORM OF EXCHANGE AGREEMENT, DATED AS OF JUNE 11, 2026, BY AND AMONG ADIAL PHARMACEUTICALS, INC. AND EACH NOTE HOLDER LISTED ON EXHIBIT A THERETO <TEXT> Document 9 - file: ea029444801ex10-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.3 <SEQUENCE>10 <FILENAME>ea029444801ex10-3.htm <DESCRIPTION>FORM OF REGISTRATION RIGHTS AGREEMENT, BY AND AMONG ADIAL PHARMACEUTICALS, INC. AND THE INVESTORS SIGNATORY THERETO <TEXT> Document 10 - file: ea029444801ex10-3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.4 <SEQUENCE>11 <FILENAME>ea029444801ex10-4.htm <DESCRIPTION>AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND CARY J. CLAIBORNE, EFFECTIVE JUNE 11, 2026 <TEXT> Document 11 - file: ea029444801ex10-4.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.5 <SEQUENCE>12 <FILENAME>ea029444801ex10-5.htm <DESCRIPTION>AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND TONY GOODMAN, EFFECTIVE JUNE 11, 2026 <TEXT> Document 12 - file: ea029444801ex10-5.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.6 <SEQUENCE>13 <FILENAME>ea029444801ex10-6.htm <DESCRIPTION>AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND VINAY SHAH, EFFECTIVE JUNE 11, 2026 <TEXT> Document 13 - file: ea029444801ex10-6.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>14 <FILENAME>ea029444801ex99-1.htm <DESCRIPTION>PRESS RELEASE ISSUED ON JUNE 11, 2026 <TEXT> Document 14 - file: ea029444801ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>15 <FILENAME>ea029444801ex99-2.htm <DESCRIPTION>INVESTOR PRESENTATION, DATED JUNE 2026 <TEXT> Document 15 - file: ea029444801ex99-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>16 <FILENAME>ea029444801_ex99-2img1.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 16 - file: ea029444801_ex99-2img1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>17 <FILENAME>ea029444801_ex99-2img2.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 17 - file: ea029444801_ex99-2img2.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>18 <FILENAME>ea029444801_ex99-2img3.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 18 - file: ea029444801_ex99-2img3.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>19 <FILENAME>ea029444801_ex99-2img4.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 19 - file: ea029444801_ex99-2img4.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>20 <FILENAME>ea029444801_ex99-2img5.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 20 - file: ea029444801_ex99-2img5.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>21 <FILENAME>ea029444801_ex99-2img6.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 21 - file: ea029444801_ex99-2img6.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>22 <FILENAME>ea029444801_ex99-2img7.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 22 - file: ea029444801_ex99-2img7.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>23 <FILENAME>ea029444801_ex99-2img8.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 23 - file: ea029444801_ex99-2img8.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>24 <FILENAME>ea029444801_ex99-2img9.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 24 - file: ea029444801_ex99-2img9.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>25 <FILENAME>ea029444801_ex99-2img10.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 25 - file: ea029444801_ex99-2img10.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>26 <FILENAME>ea029444801_ex99-2img11.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 26 - file: ea029444801_ex99-2img11.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>27 <FILENAME>ea029444801_ex99-2img12.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 27 - file: ea029444801_ex99-2img12.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>28 <FILENAME>ea029444801_ex99-2img13.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 28 - file: ea029444801_ex99-2img13.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>29 <FILENAME>ea029444801_ex99-2img14.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 29 - file: ea029444801_ex99-2img14.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>30 <FILENAME>ea029444801_ex99-2img15.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 30 - file: ea029444801_ex99-2img15.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>31 <FILENAME>ea029444801_ex99-2img16.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 31 - file: ea029444801_ex99-2img16.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>32 <FILENAME>ea029444801_ex99-2img17.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 32 - file: ea029444801_ex99-2img17.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>33 <FILENAME>ea029444801_ex99-2img18.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 33 - file: ea029444801_ex99-2img18.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>34 <FILENAME>ea029444801_ex99-2img19.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 34 - file: ea029444801_ex99-2img19.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>35 <FILENAME>ea029444801_ex99-2img20.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 35 - file: ea029444801_ex99-2img20.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>36 <FILENAME>ea029444801_ex99-2img21.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 36 - file: ea029444801_ex99-2img21.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>37 <FILENAME>ea029444801_ex99-2img22.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 37 - file: ea029444801_ex99-2img22.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>38 <FILENAME>ea029444801_ex99-2img23.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 38 - file: ea029444801_ex99-2img23.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>39 <FILENAME>ea029444801_ex99-2img24.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 39 - file: ea029444801_ex99-2img24.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>40 <FILENAME>ea029444801_ex99-2img25.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 40 - file: ea029444801_ex99-2img25.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>41 <FILENAME>ea029444801_ex99-2img26.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 41 - file: ea029444801_ex99-2img26.jpg
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>42 <FILENAME>adil-20260611.xsd <DESCRIPTION>XBRL SCHEMA FILE <TEXT> Document 42 - file: adil-20260611.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>43 <FILENAME>adil-20260611_lab.xml <DESCRIPTION>XBRL LABEL FILE <TEXT> Document 43 - file: adil-20260611_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>44 <FILENAME>adil-20260611_pre.xml <DESCRIPTION>XBRL PRESENTATION FILE <TEXT> Document 44 - file: adil-20260611_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>46 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 46 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>47 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 47 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>48 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 48 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>50 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 50 - file: FilingSummary.html
Document 50 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>52 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 52 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>53 <FILENAME>0001213900-26-067711-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 53 - file: 0001213900-26-067711-xbrl.zip
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>54 <FILENAME>ea0294448-8k_adial_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 54 - file: ea0294448-8k_adial_htm.html
Document 54 - RAW XML: ea0294448-8k_adial_htm.xml
</DOCUMENT> </SEC-DOCUMENT>